Αποτελέσματα Αναζήτησης
11 Αυγ 2024 · Methylprednisolone is an FDA-approved medication used for managing and treating various conditions, including allergic reactions, arthritis, asthma exacerbations, long-term asthma maintenance, and acute exacerbations of multiple sclerosis.
11 Αυγ 2024 · Methylprednisolone is an FDA-approved medication used for managing and treating various conditions, including allergic reactions, arthritis, asthma exacerbations, long-term asthma maintenance, and acute exacerbations of multiple sclerosis.
Methylprednisolone | C22H30O5 | CID 6741 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
23 Οκτ 2021 · Abstract. The temporal variations in the pharmacokinetics and pharmacodynamics of methylprednisolone at 8 am versus 4 pm were investigated in six healthy male volunteers. Subjects completed three phases: no drug administration, 20 mg intravenous methylprednisolone at 8 am, and the same dose at 4 pm. Methylprednisolone clearance was 28% greater ...
9 Απρ 2021 · Methylprednisolone is an option for treating ARDS. However, the benefits and adverse effects of methylprednisolone have not been well assessed in patients with ARDS. This study aimed to evaluate the efficacy and safety of methylprednisolone against ARDS.
6 Νοε 2021 · Following, a cumulative dose of IV methylprednisolone 9.5g, no improvement in the GO was observed (lack of efficacy). Subsequently, she developed exogenous Cushing disease associated with methylprednisolone [ duration of treatment to reaction onset and outcome not stated ].
A 14-year-old girl experienced rebound effect in the form of worsening of inflammatory markers, fever and renal function following weaning of methylprednisolone during treatment for systemic inflammation.
